CoChat

Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease

Bloudek, Lisa M., Spackman, D. Eldon, Blankenburg, Michael, Sullivan, Sean D. · 2011 · Journal of Alzheimer’s Disease

The DOI matches its Crossref record.

Abstract

Mild Alzheimer's disease (AD) is often difficult to differentiate from mild cognitive impairment (MCI) or non-AD dementias. A multitude of diagnostic biomarkers and advanced imaging strategies have been developed to aid in the diagnosis and management of AD. We sought to review and analyze the published evidence on key test characteristics of major diagnostic strategies to formulate best estimates of sensitivity (SN) and specificity (SP). A systematic review was undertaken to locate and abstract all studies of biomarkers or diagnostic imaging for AD published in English from January 1990 to March 2010 that provided estimates of SN and SP. Meta-analysis was performed using a bivariate mixed-effects binary regression model. We calculated -SN, SP, and area under the receiver operating curves (AUROC), with confidence and prediction contours. Of 1,840 unique studies identified, 119 presented primary data sufficient for analysis. SN and SP were calculated against non-demented controls, non-AD dementias with and without MCI, if available. Compared to non-demented controls, FDG-PET demonstrated the highest AUROC (0.96), with 90% SN (95%CI 84% to 94%), and 89% SP (95% CI 81% to 94%). FDG-PET also was most accurate in discriminating AD from demented controls (including MCI) with AUROC 0.91, and 92% SN (95%CI 84% to 96%) and 78% SP (95% CI 69% to 85%). For discrimination of AD from non-AD dementias (excluding MCI), CSF Ptau, and SPECT produced identical AUROC (0.86). Diagnostic strategies for AD show wide variation in test characteristics and some show promise for use in clinical practice.

Overview

Integrity signals

Registry

Crossref · 10.3233/jad-2011-110458

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 282

Metadata

Authors
Bloudek, L. M., Spackman, D. E., Blankenburg, M., & Sullivan, S. D.
Affiliations
  • Allergan, Inc., Irvine, CA, USA
  • University of York, Centre for Health Economics, York, UK
  • Bayer (Germany) (DE)
  • University of Washington (US)
Venue
Journal of Alzheimer’s Disease
Published
2011-10-04
Volume
26
Issue
4
Pages
627-645
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1829865020
Cited by
282
References
0
Citations by year
2026: 12 · 2025: 12 · 2024: 18 · 2023: 8 · 2022: 24 · 2021: 29 · 2020: 27 · 2019: 20 · 2018: 18 · 2017: 21 · 2016: 21 · 2015: 17 · 2014: 28 · 2013: 15 · 2012: 11
FWCI
2.19
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Alzheimer s Disease (publishedVersion)
  • PubMed (publishedVersion)
Funders
Bayer HealthCare
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
Alzheimer's disease, diagnostic biomarkers
MeSH terms
Alzheimer Disease, Diagnosis, Differential, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Neuropsychological Tests, ROC Curve, Tomography, X-Ray Computed, Biomarkers, Tomography, Emission-Computed, Single-Photon, Amyloid beta-Peptides, tau Proteins, Area Under Curve, Positron-Emission Tomography, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease. https://app.cochat.ai/papers/10.3233/jad-2011-110458
The paper
Bloudek, L. M., Spackman, D. E., Blankenburg, M., & Sullivan, S. D. (2011). Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-2011-110458

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.